ストックスクリーナーアプリを入手
7.40
0.40%
-0.03
アフターアワーズ：
7.41
0.010
+0.14%
Precision Biosciences Inc (DTIL) 最新ニュース
Precision BioSciences Inc Stock Intrinsic Values | HAM:PBS0 - GuruFocus
Precision BioSciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Competitors 2026 - GuruFocus
Precision BioSciences Inc Stock Warning Signs | HAM:PBS0 - GuruFocus
Who's Buying or Selling Precision BioSciences Inc (HAM:PBS0) Stock Today? - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock Price & 30 Year Financial Data - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock Earnings Transcripts - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
HAM:PBS0 Dividend: Does Precision BioSciences Inc Pay a Dividend? - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock Price, Trades & News - GuruFocus
Precision BioSciences Inc (HAM:PBS0) Stock News, Headlines & Updates - GuruFocus
Precision BioSciences Inc (DTIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Have Lowered Expectations For Precision BioSciences, Inc. (NASDAQ:DTIL) After Its Latest Results - webull.com
Precision BioSciences (NASDAQ:DTIL) Announces Quarterly Earnings Results - MarketBeat
Precision BioSciences (NASDAQ:DTIL) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Precision Trading with Precision Biosciences Inc. (DTIL) Risk Zones - Stock Traders Daily
Precision BioSciences, Inc. (DTIL) stock price, news, quote and history - Yahoo Finance Singapore
DTIL Looks 315.0% Overvalued on GF Value™ - GuruFocus
Form 8K Precision BioSciences Inc For: 6 August By Investing.com - Investing.com Nigeria
Precision BioSciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Precision BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Precision BioSciences Q2 net loss widens on warrant liability charge - TradingView
Precision BioSciences reports Q2 2026 net loss $32.7M; $112.4M cash supports runway through 2028 - TradingView
PRECISION BIOSCIENCES INC Q2 2026: Revenue $0 EPS $(1.26) — 10-Q Summary - TradingView
Precision BioSciences (NASDAQ: DTIL) books $10.8M H1 revenue and advances gene editing trials - Stock Titan
Precision Biosciences 2Q Loss/Shr $1.26 >DTIL - Moomoo
Precision BioSciences: Q2 Earnings Snapshot - AOL.com
Q2 EPS Forecast for Precision BioSciences Lowered by Analyst - MarketBeat
Revenue Downgrade: Here's What Analysts Forecast For Precision BioSciences, Inc. (NASDAQ:DTIL) - webull.com
Precision BioSciences Inc expected to post a loss of 79 cents a shareEarnings Preview - TradingView
Analysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Precision BioSciences (DTIL) - The Globe and Mail
H.C. Wainwright reiterates Precision BioSciences stock rating at buy By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Precision BioSciences stock rating at buy - Investing.com
Weekly Recap: Q2 2026 report date confirmed and COO and CFO appointments - TradingView
Precision Biosciences (DTIL) officer details stock and RSU holdings - Stock Titan
H.C. Wainwright Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Earnings Preview: DTIL to Report Financial Results Pre-market on August 06 - Moomoo
Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026 - The Chronicle-Journal
Precision BioSciences (DTIL) Expected to Release Quarterly Earnings on Thursday - MarketBeat
Precision BioSciences Inc (DTIL) Valuation: PE, PB & Fair Value Analysis - TradingKey
DTIL|Precision BioSciences Inc|Price:7.240|Chg%:-0.050 - TradingKey
Precision BioSciences Inc (DTIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Precision BioSciences announces leadership changes - Investing.com India
Precision BioSciences (DTIL) Announces Leadership Restructuring for Clinical Development - GuruFocus
Precision BioSciences Inc (DTIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precision BioSciences Inc (DTIL) Income Statement - TradingKey
Precision BioSciences Announces Executive Leadership Changes to Advance Gene Editing Programs - Minichart
Precision Biosciences, Inc. Announces Chief Financial Officer Changes, Effective August 1, 2026 - marketscreener.com
Precision BioSciences Announces Key Executive Leadership Changes - TipRanks
Precision BioSciences Inc (DTIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precision BioSciences (DTIL) Announces Leadership Changes - GuruFocus
Precision BioSciences appoints Alex Kelly COO; Naresh Tanna named CFO - TradingView
Precision BioSciences announces leadership changes By Investing.com - Investing.com Nigeria
Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones - Business Wire
Precision BioSciences Inc (DTIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DTIL|Precision BioSciences Inc|Price:6.990|Chg%:-0.010 - TradingKey
Precision BioSciences Elevates Alex Kelly to COO and Names Naresh Tanna as New CFO Amid Leadership Restructuring - Kalkine Media
Precision BioSciences Inc (DTIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Affinity Asset Advisors LLC Purchases Shares of 597,946 Precision BioSciences, Inc. $DTIL - MarketBeat
Lynx1 Capital Management LP Acquires Additional Shares in Precis - GuruFocus
Precision BioSciences (DTIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Focuses on Pipeline - dars.gov.et
Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance LevelCovered Call Trade - dars.gov.et
1.80%
1.77%
大文字化:
|
ボリューム (24 時間):